Founder, Chairman and Chief Scientific Officer.
Sergei holds more than 30-year experience in Materials Science and Engineering.
He is a George A. Bush, Jr. Distinguished Professor at the University of North Carolina at Chapel Hill and and Fellow of the American Physical Society. Sergei’s lab at UNC aims at the design of novel polymeric materials with unique properties for biomedical implants, soft robotics, and enhanced oil recovery. The current focus is time-programmable materials with architecturally encoded physical properties and biological functions. The research accomplishments have been internationally validated by high-impact publications in Nature, Science, and PNAS.
Sergei Sheiko received his B.S. degree in Molecular and Chemical Physics from the Moscow Institute of Physics and Technology in 1986 and his PhD in Polymer Physics from the Russian Academy of Sciences in 1991. From 1991-1993, he was a postdoctoral research associate at the University of Twente in the Netherlands with Prof. Martin Moller. In 2000, Sergei completed his Habilitation in Polymer Chemistry at the University of Ulm in Germany. He started at the University of North Carolina at Chapel Hill in 2001 and received his tenure in 2005.
Co-Founder and Chief Executive Officer.
Eric has over 35 years of professional experience, including nearly 20 years in healthcare.
Before starting BMPolytech, Eric held various leadership and legal positions in large healthcare companies including General Electric and Quintiles Transnational Corporation (now Iqvia). Most recently he was the General Counsel, Chief Compliance Officer & Secretary of inVentiv Health, Inc., which he helped to sell to INC Research, Inc, in a $9bn transaction.
He is also on the Board of Directors of Dignify Therapeutics.
Eric received an MBA from City, University of London and a JD degree from Rutgers School of Law.
Co-Founder and Chief Operating Officer.
Tatyana is a professional with 30 years of experience in pharmaceutical, medical device development, and commercial manufacturing.
Before starting BMPolytech, Tatyana held various leadership roles contributing to successful advancement of numerous drug leads and marketed pharmaceuticals, development and commercialization initiatives at companies including Biogen, Diosynth, Biolex, Synthon Pharmaceuticals, and Dignify Therapeutics.
Tatyana is also a co-founder of Dignify Therapeutics and NanoClimate and provides regulatory and CMC operational support to Bio/Pharmaceutical and medical device companies from discovery to clinical and commercial manufacturing.
Tatyana received her M.S. degree in Bioengineering from D. Mendeleev University of Chemical Technology of Russia, Department of Microbiology and Biotechnology.